McMaster University researchers find possible celiac disease treatment
Researchers at McMaster University in Ontario, Canada have discovered that a molecule called elafin could potentially provide treatment for celiac disease.
Elafin plays an important role in protecting the lining of the intestine, so when gluten inflames the intestine of celiacs, if they have decreased amounts of elafin the inflammation is increased further.
The research suggests that celiacs intestinal lining could be strengthened using elafin. While it would not allow them to eat a normal gluten containing diet, it would provide additional protection from accidental gluten ingestion, making staying on a gluten free diet a little less arduous.
The 4 year research project is being funded by The Canadian Institute of Health Research.